Messenger RNA Market - A Global and Regional Analysis

2.1 Overview
2.2 Oncology
2.3 Infectious Diseases
2.4 Rare Genetic Diseases
2.5 Respiratory Diseases
2.6 Other Applications

3.1 North America
3.1.1 Key Findings
         3.1.2 Market Dynamics
         3.1.3 Market Sizing and Forecast
                  3.1.3.1 North America Messenger RNA Market (by Country)
                              3.1.3.1.1 U.S.
                              3.1.3.1.2 Canada
3.2 Europe
         3.2.1 Key Findings
         3.2.2 Market Dynamics
         3.2.3 Market Sizing and Forecast
                  3.2.3.1 Europe Messenger RNA Market (by Country)
                              3.2.3.1.1 U.K.
                              3.2.3.1.2 Germany
                              3.2.3.1.3 France
                              3.2.3.1.4 Italy
                              3.2.3.1.5 Spain
                              3.2.3.1.6 Rest-of-Europe
3.3 Asia-Pacific
         3.3.1 Key Findings
         3.3.2 Market Dynamics
         3.3.3 Market Sizing and Forecast
                  3.3.3.1 Asia-Pacific Messenger RNA Market (by Country)
                              3.3.3.1.1 Japan
                              3.3.3.1.2 China
                              3.3.3.1.3 Rest-of-Asia-Pacific
3.4 Rest-of-the-World
         3.4.1 Key Findings
         3.4.2 Market Dynamics
         3.4.3 Market Sizing and Forecast

4.1 Competitive Landscape
      4.1.1 Key Strategies and Developments by Company
               4.1.1.1 Funding Activities
               4.1.1.2 Mergers and Acquisitions
               4.1.1.3 Regulatory Approvals
               4.1.1.4 Partnerships, Collaborations and Business Expansions
      4.1.2 Key Developments Analysis
4.2 Company Profiles
      4.2.1 Arcturus Therapeutics, Inc.
4.2.1.1 Company Overview
               4.2.1.2 Product Portfolio
               4.2.1.3 Target Customers/End Users
               4.2.1.4 Analyst View
      4.2.2 ModernaTX, Inc.
               4.2.2.1 Company Overview
               4.2.2.2 Product Portfolio
               4.2.2.3 Target Customers/End Users
               4.2.2.4 Analyst View
      4.2.3 Beam Therapeutics Inc.
               4.2.3.1 Company Overview
               4.2.3.2 Product Portfolio
               4.2.3.3 Target Customers/End Users
               4.2.3.4 Analyst View
      4.2.4 AstraZeneca
               4.2.4.1 Company Overview
               4.2.4.2 Product Portfolio
               4.2.4.3 Target Customers/End Users
               4.2.4.4 Analyst View
      4.2.5 SK Bioscience Co., Ltd.
               4.2.5.1 Company Overview
               4.2.5.2 Product Portfolio
               4.2.5.3 Target Customers/End Users
               4.2.5.4 Analyst View               
      4.2.6 Oncotelic Inc.
               4.2.6.1 Company Overview
               4.2.6.2 Product Portfolio
               4.2.6.3 Target Customers/End Users
               4.2.6.4 Analyst View
      4.2.7 Sanofi
               4.2.7.1 Company Overview
               4.2.7.2 Product Portfolio
               4.2.7.3 Target Customers/End Users
               4.2.7.4 Analyst View
      4.2.8 Sangamo Therapeutics
               4.2.8.1 Company Overview
               4.2.8.2 Product Portfolio
               4.2.8.3 Target Customers/End Users
               4.2.8.4 Analyst View
      4.2.9 Pfizer               
               4.2.9.1 Company Overview
               4.2.9.2 Product Portfolio
               4.2.9.3 Target Customers/End Users
               4.2.9.4 Analyst View
      4.2.10 CureVac N.V.
               4.2.10.1 Company Overview
               4.2.10.2 Product Portfolio
               4.2.10.3 Target Customers/End Users
               4.2.10.4 Analyst View
      4.2.11 GlaxoSmithKline plc
               4.2.11.1 Company Overview
               4.2.11.2 Product Portfolio
               4.2.11.3 Target Customers/End Users
               4.2.11.4 Analyst View

Table:       Global Messenger RNA Market, Regulatory Scenario
Table:       Global Messenger RNA Market Dynamics, Impact Analysis
Table:       Global Messenger RNA Market (by Application), $Million, 2023-2035

Figure:       Global Messenger RNA Market, Market Overview
Figure:       Global Messenger RNA Market Coverage
Figure:       Global Messenger RNA Market Key Trends, Impact Analysis, 2023-2035
Figure:       Global Messenger RNA Market, Competitive Landscape, January 2022-April 2025